Posts
February 11 2021
Stealth Bio Therapeutics Corp. announced the closing of their Registered Direct offering in the amount of $4,678,000. EG&S acted as counsel to the Placement Agent.
February 11 2021
Zomedica Pharmaceuticals Corp. announced the closing of their Underwritten offering in the amount of $173,500,000. EG&S acted as counsel to the Underwriter.
February 11 2021
InMed Pharmaceuticals, Inc. announced the closing of their PIPE offering in the amount of $4,462,500. EG&S acted as counsel to the Placement Agent.
February 10 2021
SPI Energy Co. LTD. announced the closing of their Registered Direct offering in the amount of $14,700,000. EG&S acted as counsel to the Placement Agent.
February 10 2021
Ocugen, Inc. announced the closing of their Registered Direct offering in the amount of $23,000,000. EG&S acted as counsel to the Placement Agent.
February 10 2021
Thunder Bridge Capital Partners III Inc. announced the closing of its initial public offering in the amount of $414,000,000. EGS acted as counsel to Thunder Bridge Capital Partners III Inc.
February 10 2021
February 09 2021
Cuentas, Inc. announced the closing of its upsized underwritten public offering in the amount of $12,000,000. EGS acted as counsel to Maxim Group LLC, the sole book-running manager for the offering.